New COVID-19 Data: A Case for Optimism?
Listen as infectious disease experts Paul E. Sax, MD, and Renslow Sherer, MD, discuss exciting new developments in COVID-19 prevention and treatment.
Decera Clinical Education Infectious Disease Podcast · Renslow Sherer MD, Paul E. Sax MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this podcast episode, Paul E. Sax, MD, and Renslow Sherer, MD, discuss the clinical significance of new data on the prevention and treatment of COVID-19, including:
- COVID-19 in immunocompromised hosts
- Prime-Boost Strategy for COVID-19 vaccination
- COVID-19 surge effects
- Monoclonal antibody therapy for prevention and treatment
- Remdesivir update
- Repurposed drug, fluvoxamine
- What does the future of the pandemic look like?
Presenters:
Paul E. Sax, MD
Clinical Director
HIV Program and Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Renslow Sherer, MD
Director
International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
Chicago, Illinois
Link to full program, including downloadable slidesets:
https://bit.ly/3zVTwYW
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.